DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oncogene
Oncogene
Ret Oncogene and Thyroid Carcinoma
A Gain-Of-Function P53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia Through the Pluripotency Factor FOXH1
Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
Targeting the Function of the HER2 Oncogene in Human Cancer Therapeutics
Extensive Analysis of the Retinoblastoma Gene in Adult T Cell Leukemia/Lymphoma (ATL) Y Hatta1, Y Yamada2, M Tomonaga2 and HP Koeffler1
Physical Interaction of the Retinoblastoma Protein with Human D Cyclins
Updated November 2019 KIT Mutation the KIT Gene Is Associated With
Genetic Testing for Germline Mutations of the RET Proto-Oncogene AHS - M2078
P53 Regulates the Transcription of Its &Delta
The Adenomatous Polyposis Coli Tumour Suppressor Gene Regulates C-MYC Transcription in Colon Cancer Cells
Cancer Biology Introduction Proto-Oncogenes Tumor
Defective Human Retinoblastoma Protein Identified by Lack of Interaction with the E1A Oncoprotein I
Second, Complementing, Oncogene (Simian Virus 40 Large Tumor Antigen/Chemotherapy) TADASHI Hirakawa*T and H
Of P53-Deficient Cells (Tumor Suppressor Gene/Adfovrs Ela/Adenovirus E1B) Scorr W
KIT Somatic Mutations and Immunohistochemical Expression in Canine Oral Melanoma
Catenin Degradation and Selection of APC Mutations in Colorectal Tumours from FAP Patients
HER3/Erbb3 (Phospho-Tyr1222) Antibody
C-Met As a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
Top View
Expression of Erythroblastic Leukemia Viral Oncogene Homolog (Erbbs) Mrnas and Possible Splice Variants in 3T3-L1 Preadipocytes
Activating Mutations in HER2: Neu Opportunities and Neu Challenges
Elevated Proto-Oncogene Expression in Polycystic Kidneys of the C57BL/6J (Cpk) Mouse”2’3
The Oncogene HER2: Its Signaling and Transforming Functions and Its Role in Human Cancer Pathogenesis
Status of CHEK2 and P53 in Patients with Early‑Onset and Conventional Gastric Cancer
Coping with Stress: Multiple Ways to Activate P53
Wild-Type P53 Can Inhibit Oncogene-Mediated Focus Formation
RB and Cell Cycle Progression
Expression of the C-Met Proto-Oncogene and Its Possible Involvement in Liver Invasion in Adult T-Cell Leukemia1
The Role of MET in Chemotherapy Resistance
P53 Gene Mutations and Abnormal Retinoblastoma Protein in Radiation-Induced Human Sarcomas1
Iotest Conjugated Antibody CD135-PE
Datasheet: AHP1088 Product Details
CHEK2 C.1100Delc Mutation Is Associated with an Increased Risk for Male Breast Cancer in Finnish Patient Population Sanna Hallamies1, Liisa M
The Regulation of E2F by Prb-Family Proteins
Prognosis of Patients with Acute Myeloid Leukemia Regarding the Presence FLT3 Gene Mutation – a Case Report
Oncogene Or Tumor Suppressor Gene
HER3 Comes of Age: New Insights Into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy
Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-Directed Immunotherapy of Acute Myeloid Leukemia
HER3 Targeted Therapy
C-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences
Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation
The Proto-Oncogene C-Kit Inhibits Tumor Growth by Behaving As a Dependence Receptor Hong Wang
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather Than Checkmate
Novel C-Met Inhibitor Suppresses the Growth of C-Met-Addicted Gastric
P53: Oncogene Or Anti-Oncogene?
Mutations of the CHEK2 Gene in Patients with Cancer and Their
Elevated Expression of Erbb3 Confers Paclitaxel Resistance in Erbb2-Overexpressing Breast Cancer Cells Via Upregulation of Survivin
Findings from the Breast Cancer Association Consortium Taru A
Oncogene Addiction I
Akt Isoforms: a Family Affair in Breast Cancer
Somatic Mutations of the RET Proto-.Oncogene Are Not Required for Tumor Development in Multiple Endocrine Neoplasia Type 2 (MEN 2) Gene Carriers1
Mouse FLT-3 / CD135 / FLK-2 Protein (His Tag)
Akt/Protein Kinase B Is Constitutively Active in Non-Small Cell Lung Cancer Cells and Promotes Cellular Survival and Resistance to Chemotherapy and Radiation
Genes and Cancer What Are Genes?
Overexpression and Constitutive Activation of FLT3 Induces STAT5 Activation in Primary Acute Myeloid Leukemia Blast Cells1
Oncogene C-Kit in a Human Mast Cell Leukemia Cell Line Causing Ligand-Independent Activation of C-Kit Product
CHEK2-Positive Breast Cancers Inyoung Polish Women
Frequent Inactivationof the Retinoblastoma Anti-Oncogene Is
The CHEK2 Gene and Inherited Breast Cancer Susceptibility
Telomerase Is Not an Oncogene
Understanding Prb: Toward the Necessary Development of Targeted Treatments for Retinoblastoma Uma M
Oncogenes & Tumor Suppressor Genes
Prospect for Anti-HER2 Receptor Therapy in Breast Cancer
Inactivation of the APC Gene Is Constant in Adrenocortical Tumors
Iotest CD135-PE
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
CHEK2 1100Delc Is a Susceptibility Allele for HNPCC-Related
Role of CD135/CD117 on Prognosis and Overall Survival of Acute
KIT Gene KIT Proto-Oncogene Receptor Tyrosine Kinase
FLT3 Expressing Leukemias Are Selectively Sensitive to Inhibitors Of
Elevated Expression of the Proto-Oncogene C-Kit in Patients with Mastocytosis H Nagata, AS Worobec, T Semere and DD Metcalfe
PI3K/Akt: Getting It Right Matters
Do Mutations Turn P53 Into an Oncogene?
APC Mutations Are Not Confined to Hotspot Regions in Early-Onset Colorectal Cancer
FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis
The Emerging Role of the PI3-K-Akt Pathway in Prostate Cancer Progression
AKT Plays a Central Role in Tumorigenesis
Activation of P53 by Oncogenes
TUMOR-SUPPRESSOR TUMOR SUPPRESSOR GENES Molecular Oncology 2012
HER2/Neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology